[go: up one dir, main page]

WO2008081475A3 - Novel crystalline forms of zolmitriptan - Google Patents

Novel crystalline forms of zolmitriptan Download PDF

Info

Publication number
WO2008081475A3
WO2008081475A3 PCT/IN2007/000620 IN2007000620W WO2008081475A3 WO 2008081475 A3 WO2008081475 A3 WO 2008081475A3 IN 2007000620 W IN2007000620 W IN 2007000620W WO 2008081475 A3 WO2008081475 A3 WO 2008081475A3
Authority
WO
WIPO (PCT)
Prior art keywords
zolmitriptan
crystalline forms
novel crystalline
preparation
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2007/000620
Other languages
French (fr)
Other versions
WO2008081475A2 (en
Inventor
Purna Chandra Ray
Amit Rohatgi
Jetti Ramakoteswara Rao
Om Dutt Tyagi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mylan Laboratories Ltd
Original Assignee
Matrix Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matrix Laboratories Ltd filed Critical Matrix Laboratories Ltd
Publication of WO2008081475A2 publication Critical patent/WO2008081475A2/en
Publication of WO2008081475A3 publication Critical patent/WO2008081475A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides novel crystalline polymorphic forms of zolmitriptan characterized by.different solid state techniques. The novel processes for their preparation are also disclosed. Further, the present invention is also directed to novel processes for the preparation of zolmitriptan crystalline form A.
PCT/IN2007/000620 2007-01-04 2007-12-31 Novel crystalline forms of zolmitriptan Ceased WO2008081475A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN27CH2007 2007-01-04
IN27/CHE/2007 2007-01-04

Publications (2)

Publication Number Publication Date
WO2008081475A2 WO2008081475A2 (en) 2008-07-10
WO2008081475A3 true WO2008081475A3 (en) 2008-12-18

Family

ID=39358103

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2007/000620 Ceased WO2008081475A2 (en) 2007-01-04 2007-12-31 Novel crystalline forms of zolmitriptan

Country Status (1)

Country Link
WO (1) WO2008081475A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005075467A2 (en) * 2004-02-06 2005-08-18 Ciba Specialty Chemicals Holding Inc. Crystalline forms of zolmitriptan
WO2006055964A2 (en) * 2004-11-19 2006-05-26 Teva Pharmaceutical Industries Ltd. Zolmitriptan crystal forms
US20060148868A1 (en) * 2004-11-23 2006-07-06 Venkataraman Sundaram Zolmitriptan polymorphs

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005075467A2 (en) * 2004-02-06 2005-08-18 Ciba Specialty Chemicals Holding Inc. Crystalline forms of zolmitriptan
WO2006055964A2 (en) * 2004-11-19 2006-05-26 Teva Pharmaceutical Industries Ltd. Zolmitriptan crystal forms
US20060148868A1 (en) * 2004-11-23 2006-07-06 Venkataraman Sundaram Zolmitriptan polymorphs

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CAIRA M R: "CRYSTALLINE POLYMORPHISM OF ORGANIC COMPOUNDS", TOPICS IN CURRENT CHEMISTRY, SPRINGER, BERLIN, DE, vol. 198, 1 January 1998 (1998-01-01), pages 163 - 208, XP001156954, ISSN: 0340-1022 *

Also Published As

Publication number Publication date
WO2008081475A2 (en) 2008-07-10

Similar Documents

Publication Publication Date Title
WO2011039108A3 (en) Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives
WO2009036281A3 (en) Bortezomib and process for producing same
WO2011024192A3 (en) Novel polymorphs of raltegravir
WO2009095933A3 (en) Improved and novel process for the preparation of bosentan
WO2009068463A3 (en) Process for the preparation of isoindole derivatives as well as a process for the preparation of their intermediates
WO2010099441A3 (en) Synthesis of molecular sieve ssz-74 using a hydroxide-mediated gel
WO2008053334A3 (en) An improved process for preparing rosuvastatin calcium
WO2011004402A3 (en) Improved process for the preparation of ambrisentan and novel intermediates thereof
WO2009053446A3 (en) Pregabalin intermediates and process for preparing them and pregabalin
WO2009062659A3 (en) Polymorphs of enantiopure erdosteine
WO2010004578A3 (en) Novel and improved processes for the preparation of paliperidone
WO2010015656A3 (en) Alkoxypyrazoles and the process for their preparation
WO2009037538A3 (en) Process for the preparation of lamivudine form i
WO2008094617A3 (en) Crystalline forms of deferasirox
WO2007099552A3 (en) Novel crystalline form of atovastatin hemi-magnesium
WO2010039885A3 (en) Crystalline forms of dexlansoprazole
WO2009116081A3 (en) An improved process for the preparation of aprepitant
WO2010027848A3 (en) Forms of lapatinib compounds and processes for the preparation thereof
WO2008035360A3 (en) Novel crystalline forms of candesartan cilexetil, candesartan, tritylated candesartan and tritylated candesartan cilexetil
WO2006075139A3 (en) Novel process for the preparation of substituted indoles
WO2009122429A3 (en) Crystalline oxybutynin and process for preparing the same
WO2008007391A3 (en) An improved process for the preparation of valsartan
WO2007119120A3 (en) Crystalline polymorphic forms of olopatadine hydrochloride and processes for their preparation
WO2007143014A3 (en) Methods for preparing glutamic acid derivatives and intermediates thereof
WO2011061610A3 (en) Processes for preparation of polymorphic forms of lacosamide

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07870568

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07870568

Country of ref document: EP

Kind code of ref document: A2